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OBJECTIVES:There is an important heterogeneity in generic penetration among EU
countries. A North-South gradient in generics market share is often quoted with no
reference to policy. Our aim was to compare policies, conditions of penetration and
impact of the generics entries in selected countries to represent large and small,
Northern and Southern, Eastern and Western EU countries. METHODS: We identi-
fied policies and generics market share in volume and value in France, UK, Ger-
many, Poland, Greece, Hungary and Portugal. We browsed websites of EU and
national (when applicable) drug agencies, ministry of health, HTA bodies, payers,
manufacturer unions etc. We completed our research with literature search and
grey reports, as well as Datamonitor reports, IMS data and proprietary pharmavitae
database. RESULTS: There is a wide variability between countries concerning ge-
nerics entry policy. Generics are available from date of their market approval up to
180 days after. Generics prices range from par price to 60% lower than branded
product. In some countries, the generics entries impact the price of the whole class
by regulatory rules, while it may be company free decision in others. In Hungary,
brands are excluded from the market at generic entry. Besides, discount on brands
vary from 0 to 50%. Generic substitution is driven by either local mandatory re-
quirements or financial pharmacist incentives. As a consequence, the generic mar-
ket share varies between 25 to 80% in volume and 20 to 70% in value. The lowest
savings are found in Southern EU while UK and Germany have the largest savings.
Even though Hungary eliminates brands after generic entry, the mix keeps favour-
ing remaining brands in the same class. CONCLUSIONS: Generics policy varies
dramatically from one country to another. This explains the major differences
observed across countries on the drug budget associated with generic entry.
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OBJECTIVES: There has been growing attention for over-medicalization of chil-
dren. We examined trends in outpatient drug use among children in the Nether-
lands from 2005 until 2010. METHODS: The PHARMO Record Linkage System, con-
taining amongst others outpatient pharmacy dispensing data of 3.2 million
inhabitants in the Netherlands, was used for this study. For every year in the study
period 2005-2010, the number of children aged 0-18 with a dispensing for any drug
and per anatomical group was counted and extrapolated to the Netherlands, stan-
dardized for age and gender. Prevalence of use was reported per 10,000 children
and was stratified by calendar year and age group. RESULTS: In all age groups, drug
use increased between 2005-2008, but has been descending since. The highest
increase was found among adolescents (12-18 years): drug use increased from
4,910/10,000 in 2005 to 5,496/10,000 in 2008, but declined to 5,378/10,000 in 2010.
Among infants and toddlers (2 years), use of dermatologicals, anti-infectives,
respiratory drugs and drugs acting on the alimentary tract increased between 2005-
2008. Since 2008, the largest decrease was found for anti-infectives and respiratory
drugs (236 and 136/10,000, respectively). Among children (2-11 years), use of
dermatologicals, neurologicals and drugs acting on the alimentary tract increased
between 2005-2008, while use of anti-infectives decreased (192/10,000). Between
2008-2010, use of anti-infectives kept decreasing (224/10,000). Among adoles-
cents, drug use increased for all anatomical groups between 2005-2008, with the
highest increase for drugs acting on the alimentary tract, respiratory drugs, der-
matologicals and neurologicals. Between 2008-2010, use of neurologicals and drugs
acting on the alimentary tract kept increasing, while use of anti-infectives de-
creased (138/10,000). CONCLUSIONS: Drug use increased between 2005 and 2008,
especially among adolescents, but has been descending since. A substantial in-
crease in use was observed for drugs acting on the alimentary tract, dermatologi-
cals and neurologicals, while the use of anti-infectives decreased over time.
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OBJECTIVES: Bacopa monniera has been used as Ayurvedic medicine from time
immemorial to improve memory and intellect. P-glycoprotein expressed in intes-
tinal epithelia is an important efflux transporter that plays an important role in
bioavailability of orally administered drugs. However any modulation in their ac-
tivity results in altered pharmacokinetics of co-administered P-gp substrate drugs.
The aim of this study was to evaluate the dose dependent effect of Bacopa monni-
eraon intestinal P-gp activity after one week oral administration in male Sprague
Dawley rats. METHODS: Modulation in P-gp activity was evaluated by everted gut
sac methodology using digoxin (10 M) as P-gp substrate. Digoxin transported from
mucosal to serosal side of intestine was estimated using HPLC-UV method. Trans-
port of Lucifer yellow (5 M) a cellular integrity marker across intestinal sac was
estimated by fluorescent detector. Viability of tissue was assessed by monitoring
the increase in ratio of glucose transport. RESULTS: Bacopa monniera significantly
inhibited the intestinal P-gp activity by 2.17 (p0.001), 3.67 (p0.001) and 5.25
(p0.001) fold at 15.5, 31 and 62 mg/kg/day dose respectively when compared to
control. Tissue integrity was not disturbed and was found to be viable up to 90
minutes.CONCLUSIONS: Bacopa monniera inhibited the P-gp activity after one week
oral administration. Alteration in P-gp mediated pharmacokinetic parameters
might be possible.
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OBJECTIVES: To investigate the irrational prescription habit of antibiotics by med-
ical practitioners in patients of with minor diseases and diarrhea in the area.
METHODS: Eighteen pharmacies were randomly selected in various areas of Ba-
lochistan Province and 402 prescriptions of those patients with complaints of mi-
nor injuries, fever and diarrhea were evaluated for use of antibiotics. RESULTS: 303
out of 402 prescriptions (about 75 %) were containing antibiotics and the patients
with minor injuries, fever and diarrhea were using these mostly in an irrational
manner. These prescriptions were prescribed by medical practitioners of all spe-
cialties including general physicians. A small number of non medical doctors
(about 2%) were also responsible for these prescriptions. These antibiotics were
mainly Flouroquinolones, Aminoglycosides and Beta-Lactams CONCLUSIONS:
This study indicates that this type of irrational practice is the reflection of state and
regulatory affairs in the country and this is a warning for all developing countries
which need strict regulations for antibiotics prescriptions especially when there is
no need.
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OBJECTIVES:To asses and obtain data on the present irrational use and prescribing
habit of medical practitioners for prescribing antibiotics for children in general
symptoms and diarrhea. METHODS: Prescriptions of child patients were analyzed
from May 2010 to March 2012 from 2 public/general Hospitals and 10 private clinics
in different community areas. The data were directly interpreted and analyzed
over the dispensing counters of Pharmacies by Hospital and community
Pharmacists. RESULTS: In public/general hospital 420 out of 560 (75%) patients
were prescribed antibiotics for diarrhea, fever, otitis media and minor injuries,
where as in private clinics 191 out of 210 (91%) of the patients were prescribed at
least one antibiotic for these diseases. The antibiotics were mainly Amoxicillin,
Co-amoxiclav, Ciprofloxacin, Norfloxacin and Flouroquinolones. It was also ob-
served that in some cases the antibiotics of choice was not recommended. This
irrational prescribing habit of the medical practitioners was observed everywhere
in the area both in public Hospitals and in private clinics. CONCLUSIONS: This
study showed that the irrational antibiotic use in children is a common practice
which is an alarming situation and needs strict regulatory strategies for control.
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OBJECTIVES: Risk adjustment models allow stratifying the population, considering
chronic disease as a predictor of drug costs. In this paper, we analyze outpatient
drug spending using Clinical Risk Groups (CRG) to obtain patient risk stratification.
METHODS: The study included 5,248,276 patients living in Valencian Community.
The classification of patients was carried out using CRG. The necessary information
was obtained from existing records in the database of Primary Health Care (PHC)
pharmaceutical information system GAIA, and the computer application ABUCA-
SIS. We analyzed the predictive power of the model using regression analysis,
taking as the dependent variable the neperian logarithm of the annual PHC drug
costs per patient, and as independent variables the health status of patients, de-
mographic characteristics, use of health system. RESULTS: The CRG3 groups 5 and
6 represent a 74, 4% of total pharmaceutical spending while patients in this group
are only 25% of the total. The system of grouping patients CRG3 is a good predictor
of drug expenditures, except for the CRG3 groups 8 and 9 The model obtained could
be a useful tool for managing pharmaceutical budget policies and patient
management.CONCLUSIONS:To use the CRG3 grouping system is generally a good
estimator of pharmaceutical expenditure in primary care. However, the CRG3
groups should be adjusted according to their pharmaceutical expenditure in hos-
pital pharmacy.
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OBJECTIVES: Conduct qualitative and quantitative surveys and evaluate the per-
ception of parallel trade (PT) of pharmaceuticals among pharmacists and consum-
ers in Poland; learn about experiences concerning PT phenomenon; develop and
verify hypotheses concerning potential PT risks and opportunities. METHODS: In-
dividual in-depth interview (IDI) and focus group interview (FGI) with PT experts,
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